Aggreko India to Invest 400 Crore in Maharashtra Manufacturing Centre New York Fed Study LowerIncome Households Most Affected by Rising Gas Prices Could US Consumer Confidence Stage a Recovery Economists Weigh Persistent Pessimism Potential USIran Nuclear Deal Raises Concerns Over Strait of Hormuz Security Trump Ally Warns Bahrain Minister Hails UKGulf Trade Deal as Monumental Achievement White House Security Incident Secret Service Shoots Suspect Bystander Critically Injured Potential Market Impacts BNAI Q3 2025 Earnings EPS Beat Surprises Market but Revenue Remains Absent Airship AI Holdings Q3 2025 Earnings EPS Falls Sharply Short of Estimates as Stock Rallies XPO Q1 2026 Earnings Earnings Surpass Estimates as Profitability Improves First Northwest Bancorp FNWB Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Edges Higher Lineage Cell Therapeutics Inc LCTX Q1 2026 Earnings Miss on EPS as ClinicalStage Biotech Continues Development EVGO Q1 2026 Earnings EPS Beat Surprises Amidst Unreported Revenue Emergent BioSolutions EBS Slips 142 as Stock Navigates Key Support Levels HCICU Holds Steady at 1004 Hennessy Capital Investment Corp VIII Units Mark Time Tyson Foods TSN Faces Selling Pressure Testing Key Support Levels Sol Strategies STKE Faces Renewed Selling Pressure After 56 Decline Altimmune ALT Gains Ground Navigating Support and Resistance Levels AEVA Q1 2026 Earnings EPS Beat Drives Significant Stock Rally Climb Bio Inc Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Sentiment FFWM Q4 2025 Earnings Deep EPS Miss Overshadowed by Positive Stock Reaction Huntington Bancshares HBANZ Q1 2026 Earnings Preferred Stock EPS Falls Short of Estimates Amid Narrowing Net Interest Margin FROG Q1 2026 Earnings Strong Earnings Beat Drives Shares Higher Guidance in Focus flyExclusive Inc FLYX Q1 2026 Earnings EPS Surpasses Estimates Despite Sparse Revenue Disclosure Israeli and Palestinian Entrepreneurs Forge CrossBorder Partnerships Amid Ongoing Conflict MSGE Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher Regentis Biomaterials RGNT Holds Steady at 197 as Bulls Eye Breakout Above 207